Editorial Comment: Overall survival prediction in metastatic castration-resistant prostate cancer treated with radium-223

Castration Resistant ◽

Radium 223 ◽

Overall Survival Prediction

Overall survival prediction in metastatic castration-resistant prostate cancer treated with radium-223

International braz j urol ◽

10.1590/s1677-5538.ibju.2019.0343 ◽

2020 ◽

Vol 46 (4) ◽

pp. 599-611 ◽

Cited By ~ 2

Author(s):

Monica Vidal ◽

Alejandro Delgado ◽

Carlos Martinez ◽

José Jaime Correa ◽

Isabel Cristina Durango

Keyword(s):

Prostate Cancer ◽

Overall Survival ◽

Survival Prediction ◽

Castration Resistant ◽

Radium 223 ◽

Overall Survival Prediction

A 3-variable prognostic score (3-PS) for overall survival prediction in metastatic castration-resistant prostate cancer treated with 223Radium-dichloride

Annals of Nuclear Medicine ◽

10.1007/s12149-017-1228-6 ◽

2017 ◽

Vol 32 (2) ◽

pp. 142-148 ◽

Cited By ~ 16

Author(s):

Viviana Frantellizzi ◽

Alessio Farcomeni ◽

Giulia Anna Follacchio ◽

Massimiliano Pacilio ◽

Rosanna Pellegrini ◽

...

Keyword(s):

Prostate Cancer ◽

Overall Survival ◽

Prognostic Score ◽

Survival Prediction ◽

Castration Resistant ◽

Overall Survival Prediction

Response to Editorial Comment to Impact of prior local therapy on overall survival in men with metastatic castration-resistant prostate cancer: Results from Shared Equal Access Regional Cancer Hospital

International Journal of Urology ◽

10.1111/iju.13861 ◽

2018 ◽

Vol 25 (12) ◽

pp. 1005-1005 ◽

Author(s):

Devin N Patel ◽

Brian F Chapin ◽

Stephen J Freedland

Keyword(s):

Prostate Cancer ◽

Overall Survival ◽

Editorial Comment ◽

Local Therapy ◽

Equal Access ◽

Castration Resistant ◽

Cancer Hospital

Comment on: ‘Impact of DNA damage repair defects on response to radium-223 and overall survival in metastatic castration-resistant prostate cancer’ by De Vincentis et al

European Journal of Cancer ◽

10.1016/j.ejca.2020.09.041 ◽

2020 ◽

Author(s):

Giuseppe De Vincentis ◽

Viviana Frantellizzi

Keyword(s):

Prostate Cancer ◽

Dna Damage ◽

Overall Survival ◽

Dna Damage Repair ◽

Castration Resistant ◽

Radium 223 ◽

Damage Repair

Response to comment on “Impact of DNA damage repair defects on response to radium-223 and overall survival in metastatic castration-resistant prostate cancer”

European Journal of Cancer ◽

10.1016/j.ejca.2020.11.041 ◽

2020 ◽

Author(s):

Maarten J. van der Doelen ◽

Peter H.J. Slootbeek ◽

Niven Mehra

Keyword(s):

Prostate Cancer ◽

Dna Damage ◽

Overall Survival ◽

Dna Damage Repair ◽

Castration Resistant ◽

Radium 223 ◽

Damage Repair

Changes in alkaline phosphatase (ALP) dynamics and overall survival (OS) in metastatic castration-resistant prostate cancer (mCRPC) patients treated with radium-223 in an international early access program (EAP)

Annals of Oncology ◽

10.1093/annonc/mdw372.35 ◽

2016 ◽

Vol 27 ◽

pp. vi255 ◽

Cited By ~ 2

Author(s):

D. Heinrich ◽

S. Gillessen ◽

A. Heidenreich ◽

D. Keizman ◽

J.M. O'Sullivan ◽

...

Keyword(s):

Prostate Cancer ◽

Overall Survival ◽

Alkaline Phosphatase ◽

Early Access ◽

Castration Resistant ◽

Radium 223 ◽

Access Program

Changes in alkaline phosphatase (ALP) dynamics and overall survival (OS) in metastatic castration-resistant prostate cancer (mCRPC) patients treated with radium-223 in an international early access program (EAP)

Annals of Oncology ◽

10.1093/annonc/mdx423.007 ◽

2017 ◽

Vol 28 ◽

pp. vi19 ◽

Author(s):

G. Procopio ◽

G. Paganelli ◽

M. Cabria ◽

E. Cortesi ◽

M. Tucci ◽

...

Keyword(s):

Prostate Cancer ◽

Overall Survival ◽

Alkaline Phosphatase ◽

Early Access ◽

Castration Resistant ◽

Radium 223 ◽

Access Program

130 Overall survival benefit and impact on skeletal-related events for radium-223 chloride (Alpharadin) in the treatment of castration-resistant prostate cancer (CRPC) patients with bone metastases: A phase III randomized trial (ALSYMPCA)

European Urology Supplements ◽

10.1016/s1569-9056(12)60129-8 ◽

2012 ◽

Vol 11 (1) ◽

pp. e130-e130a ◽

Cited By ~ 5

Author(s):

C. Parker ◽

D. Heinrich ◽

S.I. Helle ◽

J.M O'Sullivan ◽

S Fossä ◽

...

Keyword(s):

Prostate Cancer ◽

Overall Survival ◽

Bone Metastases ◽

Survival Benefit ◽

Phase Iii ◽

Castration Resistant ◽

Radium 223 ◽

Skeletal Related Events ◽

Overall Survival Benefit

Editorial Comment to Impact of prior local therapy on overall survival in men with metastatic castration-resistant prostate cancer: Results from Shared Equal Access Regional Cancer Hospital

International Journal of Urology ◽

10.1111/iju.13837 ◽

2018 ◽

Vol 25 (12) ◽

pp. 1004-1004 ◽

Author(s):

Filip Poelaert ◽

Peter Schatteman ◽

Nicolaas Lumen

Keyword(s):

Prostate Cancer ◽

Overall Survival ◽

Editorial Comment ◽

Local Therapy ◽

Equal Access ◽

Castration Resistant ◽

Cancer Hospital

Alkaline phosphatase (ALP) normalization and overall survival in patients with bone metastases from castration-resistant prostate cancer (CRPC) treated with radium-223.

Journal of Clinical Oncology ◽

10.1200/jco.2011.29.15_suppl.4620 ◽

2011 ◽

Vol 29 (15_suppl) ◽

pp. 4620-4620 ◽

Cited By ~ 6

Author(s):

S. Nilsson ◽

C. G. O'Bryan-Tear ◽

B. Bolstad ◽

A. Lokna ◽

C. C. Parker

Keyword(s):

Prostate Cancer ◽

Overall Survival ◽

Alkaline Phosphatase ◽

Bone Metastases ◽

Castration Resistant ◽

Radium 223